Answers are grounded in this paper and cite their sources.
A new and converged route is described for synthesis of pyrvinium, an anthelmintic and antitumor agent.This method uses easily obtained materials and simple and practical reactions, including the key Friedländer condensation, to form the quinoline ring.The final product is generated through eight steps, with 23% yield and 96.6% purity (HPLC).This synthetic pyrvinium effectively inhibits β-catenin/Tcf4 driven TOP-luciferase activity, with an IC 50 value < 1 µM, and induces colon cancer cell death in a dose-dependent manner with an IC 50 of 0.54 ± 0.06 µM.Pyrvinium (1, Scheme 1), a FDA-approved drug, is used in the treatment of enterobiasis caused by Enterobius vermicularis (pinworm). 1Recent research has indicated it to be a potent inhibitor of Wnt/β-catenin signaling pathway (EC 50 ~ 10 nM). 2 This pathway underlies many human cancers through mutations in the APC, axin, and β-catenin genes. 3Inappropriate activation of the Wnt pathway is believed to be the initial event leading to colorectal cancer, as well as a number of other cancers.As such, this pathway is a therapeutic target of great interest to the field. 4e previous synthetic route of 1 is depicted in Scheme 1. 5 The quinoline intermediate 6 was prepared using a Skraup synthesis in ~ 20% yield over three steps.6 The pyrrole-aldehyde intermediate 11 was synthesized through the Paal-Knorr and Vilsmeier-Haack reactions respectively in 60% yield.The final product 1 was obtained by reaction of 11 with the methylquinolinium 7 in a piperidine condition, with 40% yield.
No takes yet. Share an insight, caveat, or question.
An et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: